168 related articles for article (PubMed ID: 30565301)
1. New and emerging renal entities: a perspective post-WHO 2016 classification.
Trpkov K; Hes O
Histopathology; 2019 Jan; 74(1):31-59. PubMed ID: 30565301
[TBL] [Abstract][Full Text] [Related]
2. WHO 2022 landscape of papillary and chromophobe renal cell carcinoma.
Lobo J; Ohashi R; Amin MB; Berney DM; Compérat EM; Cree IA; Gill AJ; Hartmann A; Menon S; Netto GJ; Raspollini MR; Rubin MA; Tan PH; Tickoo SK; Tsuzuki T; Turajlic S; Zhou M; Srigley JR; Moch H
Histopathology; 2022 Oct; 81(4):426-438. PubMed ID: 35596618
[TBL] [Abstract][Full Text] [Related]
3. The WHO 2022 Classification of Renal Neoplasms (5th Edition): Salient Updates.
Goswami PR; Singh G; Patel T; Dave R
Cureus; 2024 Apr; 16(4):e58470. PubMed ID: 38765391
[TBL] [Abstract][Full Text] [Related]
4. The New WHO Category of "Molecularly Defined Renal Carcinomas": Clinical and Diagnostic Features and Management Implications.
Kanakaraj J; Chang J; Hampton LJ; Smith SC
Urol Oncol; 2024 Jul; 42(7):211-219. PubMed ID: 38519377
[TBL] [Abstract][Full Text] [Related]
5. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.
Moch H; Amin MB; Berney DM; Compérat EM; Gill AJ; Hartmann A; Menon S; Raspollini MR; Rubin MA; Srigley JR; Hoon Tan P; Tickoo SK; Tsuzuki T; Turajlic S; Cree I; Netto GJ
Eur Urol; 2022 Nov; 82(5):458-468. PubMed ID: 35853783
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Biomarkers in Renal Cell Tumors According to the Latest WHO Classification: A Focus on Selected New Entities.
Sanguedolce F; Mazzucchelli R; Falagario UG; Cormio A; Zanelli M; Palicelli A; Zizzo M; Eccher A; Brunelli M; Galosi AB; Carrieri G; Cormio L
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791935
[TBL] [Abstract][Full Text] [Related]
7. Recurrent
Palathingal Bava E; Gupta N; Alruwaii FI; Nelson R; Al-Obaidy KI
Int J Surg Pathol; 2024 Feb; ():10668969241228295. PubMed ID: 38311893
[TBL] [Abstract][Full Text] [Related]
8. Warthin-like papillary renal cell carcinoma: A case report.
Li XF; Wang ZJ; Zhang HM; Yang MQ
World J Clin Cases; 2023 Oct; 11(30):7450-7456. PubMed ID: 37969440
[TBL] [Abstract][Full Text] [Related]
9. Atrophic Kidney-Like Lesion-Case Report and Review of the Literature.
Wang X; Lovelace E; Pacheco RR; Pacheco R; Schuster ME; Bernstein A; Akgul M; Lightle A
Int J Surg Pathol; 2024 Jan; ():10668969241226703. PubMed ID: 38291647
[TBL] [Abstract][Full Text] [Related]
10. The World Health Organization 2022 Classification of renal tumors: key updates for urologists.
Caliò A; Amparore D; Roussel E; Bertolo R; Erdem S; Marchioni M; Pavan N; Campi R;
Minerva Urol Nephrol; 2023 Dec; 75(6):766-769. PubMed ID: 38126288
[No Abstract] [Full Text] [Related]
11. Renal cell carcinoma staging: pitfalls, challenges, and updates.
Williamson SR; Taneja K; Cheng L
Histopathology; 2019 Jan; 74(1):18-30. PubMed ID: 30565307
[TBL] [Abstract][Full Text] [Related]
12. Grading of renal cell carcinoma.
Delahunt B; Eble JN; Egevad L; Samaratunga H
Histopathology; 2019 Jan; 74(1):4-17. PubMed ID: 30565310
[TBL] [Abstract][Full Text] [Related]
13. Clear cell renal cell carcinoma with wild-type von Hippel-Lindau gene: a non-existent or new tumour entity?
Batavia AA; Schraml P; Moch H
Histopathology; 2019 Jan; 74(1):60-67. PubMed ID: 30565303
[TBL] [Abstract][Full Text] [Related]
14. ESC, ALK, HOT and LOT: Three Letter Acronyms of Emerging Renal Entities Knocking on the Door of the WHO Classification.
Siadat F; Trpkov K
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31936678
[TBL] [Abstract][Full Text] [Related]
15. [Provisional renal cell carcinoma subsets following the 2016 WHO classification].
Jenei A; Hes O; Kuthi L
Orv Hetil; 2020 Jan; 161(3):83-94. PubMed ID: 31928058
[TBL] [Abstract][Full Text] [Related]
16. Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): a distinct entity?
Trpkov K; Williamson SR; Gao Y; Martinek P; Cheng L; Sangoi AR; Yilmaz A; Wang C; San Miguel Fraile P; Perez Montiel DM; Bulimbasić S; Rogala J; Hes O
Histopathology; 2019 Aug; 75(2):174-184. PubMed ID: 30895640
[TBL] [Abstract][Full Text] [Related]
17. Precursor lesions of the urinary bladder.
McKenney JK
Histopathology; 2019 Jan; 74(1):68-76. PubMed ID: 30565304
[TBL] [Abstract][Full Text] [Related]
18. The history of urologic pathology: an overview.
Young RH; Eble JN
Histopathology; 2019 Jan; 74(1):184-212. PubMed ID: 30565309
[TBL] [Abstract][Full Text] [Related]
19. Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Trpkov K; Williamson SR; Gill AJ; Adeniran AJ; Agaimy A; Alaghehbandan R; Amin MB; Argani P; Chen YB; Cheng L; Epstein JI; Cheville JC; Comperat E; da Cunha IW; Gordetsky JB; Gupta S; He H; Hirsch MS; Humphrey PA; Kapur P; Kojima F; Lopez JI; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Menon S; Netto GJ; Przybycin CG; Rao P; Rao Q; Reuter VE; Saleeb RM; Shah RB; Smith SC; Tickoo S; Tretiakova MS; True L; Verkarre V; Wobker SE; Zhou M; Hes O
Mod Pathol; 2021 Jun; 34(6):1167-1184. PubMed ID: 33526874
[TBL] [Abstract][Full Text] [Related]
20. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer.
Williamson SR; Gill AJ; Argani P; Chen YB; Egevad L; Kristiansen G; Grignon DJ; Hes O
Am J Surg Pathol; 2020 Jul; 44(7):e47-e65. PubMed ID: 32251007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
